To this end, non-sulfated 50 kDA HA and sHA fragments of the same molecular size were used to treat two breast cancer cell lines of different ER status: the less invasive ERα-positive MCF-7 and the highly aggressive ERα-negative/ERβ-positive MDA-MB-231 cells. The gene discussed is ESR2; the disease is breast carcinoma.